Max Healthcare Institute Limited (MAXHEALTH.NS)
INR 1197.45
(0.35%)
INR 1197.45
(0.35%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 54.06 Billion | 45.62 Billion | 38.83 Billion | 24.82 Billion | 18.61 Billion | 16.71 Billion |
| Cost of Revenue | 34.14 Billion | 9.22 Billion | 9.22 Billion | 5.94 Billion | 3.91 Billion | 3.65 Billion |
| Gross Profit | 19.91 Billion | 36.4 Billion | 29.6 Billion | 18.88 Billion | 14.69 Billion | 13.05 Billion |
| Operating Expenses | 7.44 Billion | 26.32 Billion | 21.84 Billion | 16.04 Billion | 12.91 Billion | 12.49 Billion |
| Selling, General and Administrative Expenses | 7.44 Billion | 9.86 Billion | 9.52 Billion | 6 Billion | 5.17 Billion | 4.77 Billion |
| Research and Development Expenses | 5.1 Million | 3.6 Million | -1.59 Billion | - | - | - |
| Other Expenses | - | 268.6 Million | 109.6 Million | 100 Million | 84.5 Million | 65.4 Million |
| Cost and Expenses | 31.7 Billion | 35.54 Billion | 31.07 Billion | 21.98 Billion | 16.82 Billion | 16.15 Billion |
| Operating Income | 22.35 Billion | 10.24 Billion | 7.57 Billion | 2.43 Billion | 482.2 Million | 569.1 Million |
| Interest Expense | 598.9 Million | 838.6 Million | 900.1 Million | 1.71 Billion | 1.47 Billion | 961.8 Million |
| Income Tax Expense | 3.07 Billion | -397.9 Million | 1.33 Billion | 458.5 Million | -62.6 Million | 85.1 Million |
| Earnings before Tax | 13.65 Billion | 10.63 Billion | 7.38 Billion | -686.5 Million | 890.8 Million | 83.2 Million |
| Net Income | 10.57 Billion | 11.03 Billion | 6.05 Billion | -1.37 Billion | 953.4 Million | -30.1 Million |
| Earnings Per Share Basic | 10.89 | 11.38 | 6.25 | -1.59 | 1.77 | -0.06 |
| Earnings Per Share Diluted | 10.84 | 11.36 | 6.24 | -1.59 | 1.77 | -0.06 |
| Weighted Average Shares Outstanding | 971.2 Million | 970.06 Million | 967.46 Million | 863.19 Million | 537.24 Million | 537.24 Million |
| Weighted Average Shares Outstanding (Diluted) | 975.45 Million | 971.71 Million | 969.38 Million | 863.19 Million | 537.24 Million | 545.71 Million |
| Gross Margin | 0.37 | 0.80 | 0.76 | 0.76 | 0.79 | 0.78 |
| EBIT Margin | 0.31 | 0.30 | 0.28 | 0.22 | 0.19 | 0.12 |
| Profit Margin | 0.20 | 0.24 | 0.16 | -0.06 | 0.05 | -0.00 |
| EBITDA | 16.7 Billion | 13.79 Billion | 10.6 Billion | 2.84 Billion | 1.41 Billion | 2.12 Billion |
| Earnings Before Tax Margin | 0.41 | 0.22 | 0.20 | 0.10 | 0.03 | 0.03 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 15.42 Billion | 54.06 Billion | 14.22 Billion | 13.34 Billion | 13.63 Billion | 12.84 Billion |
| Cost of Revenue | 10.01 Billion | 34.14 Billion | 9 Billion | 2.67 Billion | 2.79 Billion | 2.75 Billion |
| Gross Profit | 5.41 Billion | 19.91 Billion | 5.22 Billion | 10.67 Billion | 10.83 Billion | 10.09 Billion |
| Operating Expenses | 2.31 Billion | 7.44 Billion | 2.11 Billion | 7.42 Billion | 7.53 Billion | 7.27 Billion |
| Selling, General and Administrative Expenses | 2.31 Billion | - | 2.11 Billion | 2.76 Billion | 2.77 Billion | 2.71 Billion |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 37.3 Million | 218.7 Million | 70.6 Million | 54.2 Million | 41.5 Million | 52.4 Million |
| Cost and Expenses | 12.32 Billion | 41.58 Billion | 11.11 Billion | 10.1 Billion | 10.33 Billion | 10.03 Billion |
| Operating Income | 3.1 Billion | 12.47 Billion | 3.11 Billion | 3.7 Billion | 3.74 Billion | 2.81 Billion |
| Interest Expense | 238.8 Million | 598.9 Million | 207.3 Million | 112.4 Million | 85.3 Million | 193.9 Million |
| Income Tax Expense | 850.4 Million | 3.07 Billion | 841.9 Million | 703.4 Million | 897.4 Million | 634.1 Million |
| Earnings before Tax | 3.21 Billion | 13.65 Billion | 3.35 Billion | 3.59 Billion | 3.66 Billion | 3.03 Billion |
| Net Income | 2.36 Billion | 10.57 Billion | 2.51 Billion | 2.89 Billion | 2.76 Billion | 2.4 Billion |
| Earnings Per Share Basic | 2.43 | - | 2.59 | 2.98 | 2.85 | 2.47 |
| Earnings Per Share Diluted | 2.42 | - | 2.58 | 2.97 | 2.84 | 2.46 |
| Weighted Average Shares Outstanding | 971.91 Million | 971.2 Million | 971.82 Million | 971.82 Million | 971.58 Million | 971.42 Million |
| Weighted Average Shares Outstanding (Diluted) | 976.32 Million | 975.68 Million | 974.2 Million | 974.2 Million | 974.22 Million | 975.93 Million |
| Gross Margin | 0.35 | 0.37 | 0.37 | 0.80 | 0.79 | 0.79 |
| EBIT Margin | 0.25 | - | 0.27 | 0.32 | 0.32 | 0.29 |
| Profit Margin | 0.15 | 0.20 | 0.18 | 0.22 | 0.20 | 0.19 |
| EBITDA | 3.87 Billion | - | 3.81 Billion | 4.31 Billion | 4.32 Billion | 3.78 Billion |
| Earnings Before Tax Margin | 0.20 | 0.23 | 0.22 | 0.28 | 0.28 | 0.22 |
PHVS
TI
LXCHEM
ULVR
RY4C
DOM